A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy

European Heart Journal

Volumn 30, Issue 13, 2009, Pages 1648-1655

  Friedrich, Felix W ^a   Bausero, Pedro ^b,c   Sun, Yuli ^a   Treszl, Andras ^a   Krämer, Elisabeth ^a   Juhr, Denise ^a   Richard, Pascale ^b,c,d   Wegscheider, Karl ^a   Schwartz, Ketty ^b,c   Brito, Dulce ^e   Arbustini, Eloisa ^f   Waldenström, Anders ^g   Isnard, Richard ^b,c,h   Komajda, Michel ^b,c,h   Eschenhagen, Thomas ^a   Carrier, Lucie ^a,b,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h Institut de Cardiologie   (France)

Author keywords

Calcium; Cardiomyopathy; Genetics; Hypertrophy; Myocardium

Indexed keywords

LUCIFERASE;

ADULT; ANIMAL CELL; ARTICLE; CALMODULIN 3 GENE; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ADULT; AGE DISTRIBUTION; AGED; ANIMALS; BASE SEQUENCE; CALMODULIN; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RATS; TRANSFECTION;

EID: 67650086995     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp153     Document Type: Article

References (45)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276.
2. Richardson P, McKenna W, Bristow M, Maish B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93:841-842.
3. Wynne J, Braunwald E. The cardiomyopathies and myocarditis: toxix, chemical, and physical damage to the heart. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 1992. p1394-1450.
4. Richard P, Villard E, Charron P, Isnard R. The genetic bases of cardiomyopathies. J Am Coll Cardiol 2006;48:A79-A89.
5. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann JS, Weissenbach J, Vosberg HP, Fiszman M, Komajda M, Schwartz K Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995;11:438-440.
6. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995;11:434-437.
7. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyo- pathy: a b cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
8. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations and implications for molecular diagnosis strategy. Circulation 2003;107:2227-2232.
9. Forissier JF, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Faure S, Dubourg O, Millaire A, Hagege AA, Desnos M, Komajda M, Schwartz K. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996;94:3069-3073.
10. Thierfelder L, Watkins H, MacRae C, Limas R, McKenna W, Vosberg HP, Seidman JC, Seidman CE. a-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701 -712.
11. Karibe A, Tobacman LS, Strand J, Butters C, Back N, Bachinsky LL, Arai AE, Ortiz A, Roberts R, Homsher E, Fananapazir L. Hypertrophic cardiomyopathy caused by a novel a-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 2001;103:65-71.
12. Coviello DA, Maron BJM, Spirito P, Watkins H, Vosberg HP, Thierfelder L, Schoen FJ, Seidman JG, Seidman CE. Clinical features of hypertrophic cardiomyo- pathy caused by mutation of a 'hot spot' in the alpha-tropomyosin gene. J Am Coll Cardiol 1997;29:635-640.
13. Dausse E, Schwartz K. Genetic heterogeneity offamilial hypertrophic cardiomyo-pathy. Neuromusc Disord 1993;3:483 -486.
14. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagège AA, Trent RJ, Komajda M, Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997;80:427-434.
15. Marian AJ. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 2002;17:242-252.
16. Tesson F, Dufour C, Moolman JC, Carrier L, Al-Mahdawi S, Brink P, Komajda M, Guicheney P, Schwartz K, Feingold J. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. JMol Cell Cardiol 1997;29:831 -838.
17. Osterop AP, Kofflard MJ, Sandkuijl LA, ten Cate FJ, Krams R, Schalekamp MA, Danser AH. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension 1998;32:825-830.
18. DeinumJ, van GoolJM, Kofflard MJ, ten Cate FJ, Danser AH. Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy. Hypertension 2001;38:1278-1281.
19. Ortlepp JR, Vosberg HP, Reith S, Ohme F, Mahon NG, Schroder D, Klues HG, Hanrath P, McKenna WJ. Genetic polymorphisms in the renin-angiotensin- aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 2002;87:270-275.
20. Poirier O, Nicaud V, McDonagh T, Dargie HJ, Desnos M, Dorent R, Roizes G, Schwartz K, Tiret L, Komajda M, Cambien F. Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy. Eur JHum Genet 2003;11:659-664.
21. Chiu C, Tebo M, Ingles J, Yeates L, Arthur JW, Lind JM, Semsarian C. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2007;43:337-343.
22. Berchtold MW, Egli R, Rhyner JA, Hameister H, Strehler EE. Localization of the human bona fide calmodulin genes CALM1, CALM2, and CALM3 to chromosomes 14q24-q31, 2p21.1-p21.3, and 19q13.2-q13.3. Genomics 1993;16:461- 465.
23. Richards EJ. Preparation and Analysis of DNA. New York: John Wiley & Sons, Inc.; 1987.
24. Koller M, Strehler EE. Functional analysis of the promoters of the human CaMIII calmodulin gene and of the intronless gene coding for a calmodulin-like protein. Biochim Biophys Acta 1993;1163:1 -9.
25. Toutenhoofd SL, Foletti D, Wicki R, Rhyner JA, Garcia F, Tolon R, Strehler EE. Characterization of the human CALM2 calmodulin gene and comparison of the transcriptional activity of CALM1, CALM2 and CALM3. Cell Calcium 1998;23:323 -338.
26. Patten M, Wang W, Aminololama-Shakeri S, Burson M, Long CS. IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2000;32:1341 -1352.
27. Eschenhagen T, Friedrichsen M, Gsell S, Hollmann A, Mittmann C, Schmitz W, Scholz H, Weil J, Weinstein LS. Regulation ofthe human Gi alpha-2 gene promo- tor activity in embryonic chicken cardiomyocytes. Basic ResCardiol 1996;91(Suppl. 2):41 -46.
28. Nojima H, Sokabe H. Structural organization of calmodulin genes in the rat genome. Adv Exp Med Biol 1989;255:223-232.
29. Koller M, Schnyder B, Strehler EE. Structural organization of the human CaMIII calmodulin gene. Biochim Biophys Acta 1990;1087:180-189.
30. Ikeshima H, Yuasa S, Matsuo K, Kawamura K, Hata J, Takano T. Expression of three nonallelic genes coding calmodulin exhibits similar localization on the central nervous system of adult rats. JNeurosci Res 1993;36:111 -119.
31. Colomer J, Agell N, Engel P, Alberola-Ila J, Bachs O. Calmodulin expression during proliferative activation of human T lymphocytes. Cell Calcium 1993;14:609-618.
32. Colomer J, Agell N, Engel P, Bachs O. Expression of calmodulin and calmodulin binding proteins in lymphoblastoid cells. JCell Physiol 1994;159:542-550.
33. Ho AK, Shang K, Duffield R. Calmodulin regulation of the cholinergic receptor in the rat heart during ontogeny and senescence. Mech Ageing Dev 1986;36:143 -154.
34. Nojima H, Sokabe H. Structure of a gene for rat calmodulin. JMol Biol 1987;193:439-445.
35. Simmen RC, Tanaka T, Ts'ui KF, PutkeyJA, Scott MJ, Lai EC, Means AR. The structural organization ofthe chicken calmodulin gene. JBiol Chem 1985;260:907-912.
36. Berchtold MW, Epstein P, Beaudet AL, Payne ME, Heizmann CW, Means AR. Structural organization and chromosomal assignment of the parvalbumin gene. JBiol Chem 1987;262:8696-8701.
37. Berchtold MW. Parvalbumin genes from human and rat are identical in intron/ exon organization and contain highly homologous regulatory elements and coding sequences. J Mol Biol 1989;210:417-427.
38. Robert B, Daubas P, Akimenko MA, Cohen A, Garner I, Guenet JL, Buckingham M. A single locus in the mouse encodes both myosin light chains 1 and 3, a second locus corresponds to a related pseudogene. Cell 1984;39:129-140.
39. Nabeshima Y, Fujii-Kuriyama Y, Muramatsu M, Ogata K. Alternative transcription and two modes of splicing results in two myosin light chains from one gene. Nature 1984;308:333-338.
40. Arnold DB, Heintz N. A calcium responsive element that regulates expression of two calcium binding proteins in Purkinje cells. Proc Natl Acad Sci USA 1997;94:8842-8847.
41. Jeck CD, Zimmermann R, Schaper J, Schaper W. Decreased expression of calmodulin mRNA in human end-stage heart failure. J Mol Cell Cardiol 1994;26:99-107.
42. Vu Manh TP, Mokrane M, Georgenthum E, Flavigny J, Carrier L, Semeriva M, Piovant M, Roder L. Expression of cardiac myosin-binding protein-C (cMyBP-C) in Drosophila as a model for the study of human cardiomyopathies. Hum Mol Genet 2005;14:7-17.
43. Frey N, McKinsey TA, Olson EN. Decoding calcium signals involved in cardiac growth and function. Nat Med 2000;6:1221-1227.
44. Fiedler B, Wollert KC. Targeting calcineurin and associated pathways in cardiac hypertrophy and failure. Expert Opin Ther Targets 2005;9:963 -973.
45. Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase-development of the energy sensor concept. J Physiol 2006;574:7-15.